[1] Hosp Santa Maria, Ctr Hosp Univ Lisboa Norte, Lisbon, Portugal
[2] Umea Univ, Umea, Sweden
[3] Boston Univ, Sch Med, Boston, MA USA
[4] Hop Bicetre, Le Kremlin Bicetre, France
[5] Johns Hopkins Univ, Baltimore, MD USA
[6] Ctr Hosp Univ La Timone, Neuromuscular Disorders & ALS Dept, Marseille, France
[7] UCL, Natl Amyloidosis Ctr, London, England
[8] Mayo Clin, Dept Neurol, Rochester, MN USA
[9] Ctr Hosp Univ Santo Antonio, Porto, Portugal
[10] ERN NMD, Paris, France
[11] AstraZeneca, Late Stage Dev Cardiovasc Renal & Metab, BioPharmaceut R&D, Gaithersburg, MD USA
[12] Ionis Pharmaceut Inc, Carlsbad, CA USA
[13] AstraZeneca, Global Evidence, BioPharmaceut Med, Gothenburg, Sweden
[14] Univ Fed Rio de Janeiro, Amyloidosis Ctr, CEPARM, Univ Hosp, Rio De Janeiro, Brazil